Skip to main content
Premium Trial:

Request an Annual Quote

BD to Acquire Atto Bioscience in $25M Cash Deal

NEW YORK, July 1 (GenomeWeb News) - BD Biosciences, a division of Becton, Dickinson and Co., today announced the purchase of Atto Bioscience of Rockville, Md., in a cash transaction valued at approximately $25 million, the company said in a statement.


Atto is a high-content cell analysis imaging tools developer with sales of $3 million in 2003.


BD is buying the firm with the goal of integrating Atto's imaging platforms and BD's flow cytometry tools, the company said.





The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.